glp-1 weight loss drug news today october 2025 Study identifies benefits, risks linked to popular weight-loss drugs – WashU Medicine Dozens of new obesity drugs

Longitudinal monitoring of lipase and amylase in adults with type 2 diabetes and obesity: evidence from two phase 3 randomized clinical trials with the once-daily GLP-1 analog liraglutide [poster presentation at Digestive Disease Week 2012]

Med J Nutr Metab 13:289310 Ullah H, Tovchiga O, Daglia M, Khan H (2021) Modulating gut microbiota: an emerging approach in the prevention and treatment of multiple sclerosis

PubMed PMID: 31959736

Vitamin B12 can be supplemented in the form of cyanocobalamin or hydroxocobalamin, either orally or by parenteral route (230)

This allows the study to observe the effects of the primary agent in isolation